User profiles for Björn Busse

Björn Busse

University Medical Center Hamburg-Eppendorf (UKE)
Verified email at lbl.gov
Cited by 6335

Bone fragility in diabetes: novel concepts and clinical implications

LC Hofbauer, B Busse, R Eastell, S Ferrari… - The Lancet Diabetes & …, 2022 - thelancet.com
Increased fracture risk represents an emerging and severe complication of diabetes. The
resulting prolonged immobility and hospitalisations can lead to substantial morbidity and …

Decrease in the osteocyte lacunar density accompanied by hypermineralized lacunar occlusion reveals failure and delay of remodeling in aged human bone

B Busse, D Djonic, P Milovanovic, M Hahn… - Aging cell, 2010 - Wiley Online Library
Aging decreases the human femur’s fatigue resistance, impact energy absorption, and the
ability to withstand load. Changes in the osteocyte distribution and in their elemental …

Increased calcium content and inhomogeneity of mineralization render bone toughness in osteoporosis: mineralization, morphology and biomechanics of human …

B Busse, M Hahn, M Soltau, J Zustin, K Püschel… - Bone, 2009 - Elsevier
The differentiation and degree of the effects of mineral content and/or morphology on bone
quality remain, to a large extent, unanswered due to several microarchitectural particularities …

[HTML][HTML] The fracture mechanics of human bone: influence of disease and treatment

EA Zimmermann, B Busse, RO Ritchie - BoneKEy reports, 2015 - ncbi.nlm.nih.gov
Aging and bone diseases are associated with increased fracture risk. It is therefore pertinent
to seek an understanding of the origins of such disease-related deterioration in bone's …

Osteocytic canalicular networks: morphological implications for altered mechanosensitivity

…, D Djonic, K Püschel, M Djuric, M Amling, B Busse - ACS …, 2013 - ACS Publications
Osteocytes are ramified bone cells distributed throughout the bone matrix within a network
of micrometer-scale cavities (lacunae) and numerous nanometer-thick tunnels (canaliculi). …

Bisphosphonate-osteoclasts: changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis …

B Jobke, P Milovanovic, M Amling, B Busse - Bone, 2014 - Elsevier
Osteoclasts are unique cells capable of bone resorption and therefore have become a major
target in osteoporosis treatment strategies. Bisphosphonates suppress bone turnover via …

[PDF][PDF] Warmth prevents bone loss through the gut microbiota

…, N Suárez-Zamorano, M Spiljar, S Fabbiano, B Busse… - Cell Metabolism, 2020 - cell.com
Osteoporosis is the most prevalent metabolic bone disease, characterized by low bone mass
and microarchitectural deterioration. Here, we show that warmth exposure (34C) protects …

Chronic skin inflammation leads to bone loss by IL-17–mediated inhibition of Wnt signaling in osteoblasts

…, A Jeschke, O Graña, J Keller, B Busse… - Science translational …, 2016 - science.org
Inflammation has important roles in tissue regeneration, autoimmunity, and cancer. Different
inflammatory stimuli can lead to bone loss by mechanisms that are not well understood. We …

Vitamin D deficiency induces early signs of aging in human bone, increasing the risk of fracture

B Busse, HA Bale, EA Zimmermann… - Science translational …, 2013 - science.org
Vitamin D deficiency is a widespread medical condition that plays a major role in human
bone health. Fracture susceptibility in the context of low vitamin D has been primarily …

Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance

…, JM Lane, RO Ritchie, B Busse… - Proceedings of the …, 2017 - National Acad Sciences
Bisphosphonates are the most widely prescribed pharmacologic treatment for osteoporosis
and reduce fracture risk in postmenopausal women by up to 50%. However, in the past …